On the dynamics of tumor-immune system interactions and combined chemo- and immunotherapy
From MaRDI portal
Publication:5262546
DOI10.1007/978-88-470-2571-4_13zbMATH Open1316.92020OpenAlexW52762294MaRDI QIDQ5262546FDOQ5262546
Authors: A. d'Onofrio, Urszula Ledzewicz, Heinz Schättler 
Publication date: 16 July 2015
Published in: New Challenges for Cancer Systems Biomedicine (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/978-88-470-2571-4_13
Recommendations
- A tumor-immune model with mixed immunotherapy and chemotherapy: qualitative analysis and optimal control
- Dynamics of tumor-immune interaction under treatment as an optimal control problem
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- Analysis of the dynamics of a tumor-immune system with chemotherapy and immunotherapy and quadratic optimal control
- Chemotherapy and immunotherapy for tumors: a study of quadratic optimal control
Cited In (25)
- Efficiency of cancer treatments: \textit{in silico experiments}
- Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy
- Effects of mutations and immunogenicity on outcomes of anti-cancer therapies for secondary lesions
- A tumor-immune model with mixed immunotherapy and chemotherapy: qualitative analysis and optimal control
- In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach
- Effect of immunotherapy on the response of TICLs to solid tumour invasion
- An optimization method for treating solid tumors with combined therapy using the great deluge algorithm
- Dynamics of the cell-mediated immune response to tumour growth
- Robust domain of attraction estimation for a tumor growth model
- Probabilistically certified region of attraction of a tumor growth model with combined chemo‐ and immunotherapy
- Dynamics of Effector -Tumor- Interleukin-2 Interactions with Monod-Haldane Immune Response and Treatments
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
- Multiple colonies of cancer involved in mutual suppression with the immune system
- Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors
- Analysis of tumor/effector cell dynamics and decision support in therapy
- Dynamic response of cancer under the influence of immunological activity and therapy
- On a multiobjective optimal control of a tumor growth model with immune response and drug therapies
- Qualitative behavior of systems of tumor-\(\mathrm{CD}4^{+}\)-cytokine interactions with treatments
- On modeling the synergy of cancer immunotherapy with radiotherapy
- Chemo and immunotherapy effects on stability regions of tumor models
- Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach
- Cost-effectiveness analysis of optimal strategy for tumor treatment
- The local behavior around switching planes in a mathematical model to chemoimmunotherapy
- Mathematical analysis of a tumour-immune interaction model: a moving boundary problem
- A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy
This page was built for publication: On the dynamics of tumor-immune system interactions and combined chemo- and immunotherapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5262546)
